In addition, FLT3‐ITD alterations were recurrently acquired at relapse, whereas NRAS and FLT3‐TKD alterations were recurrently lost at relapse in the context of NPM1‐mutant AML. Here, FLT3 is linked to acute myeloid leukemia.